| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/17/2013 | CN102335440B Two gene vaccines containing different CpG (cytidine-phosphatte-guanonine) sequences PCV2 (porcine circovirus 2)-ORF2 and preparation process thereof |
| 04/17/2013 | CN102335182B Application of triacetylglucal in medicine preparation |
| 04/17/2013 | CN102335122B Mupirocin ointment and preparation method thereof |
| 04/17/2013 | CN102327343B External essential oil formula for preventing and treating beriberi |
| 04/17/2013 | CN102321547B Recombination yeast engineering bacteria expressing reticuloendotheliosis virus (REV) Gp90 protein, its construction method and application |
| 04/17/2013 | CN102319287B Mentha haplocalyx phenolic acid extract and application in preparation of medicines for resisting respiratory syncytial virus |
| 04/17/2013 | CN102277374B Preparation and application of genetic engineering subunit vaccine for infectious bursal disease |
| 04/17/2013 | CN102274343B Medicament for treating avian infectious bronchitis and preparation method thereof |
| 04/17/2013 | CN102274180B Prulifloxacin nano spheres and preparation method thereof |
| 04/17/2013 | CN102266389B Application of cortex meliae in preparation of drug for inhibiting influenza A H1N1 virus |
| 04/17/2013 | CN102250239B Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof |
| 04/17/2013 | CN102250234B Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof |
| 04/17/2013 | CN102241756B High expression of tenebrio molitor antibacterial peptide TmAMP3m in escherichia coli and application of TmAMP3m |
| 04/17/2013 | CN102205123B Preparation method of yolk antibody sustained-release preparation for preventing gosling plague |
| 04/17/2013 | CN102204911B Moxifloxacin hydrochloride pharmaceutical composition and its preparation method |
| 04/17/2013 | CN102174089B Avian influenza virus head protein as well as preparation method and application thereof |
| 04/17/2013 | CN102166219B Nasal administration preparation and application thereof |
| 04/17/2013 | CN102139051B Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia |
| 04/17/2013 | CN102106806B Method for preparing solid preparation and solid preparation |
| 04/17/2013 | CN102091257B Chinese medicinal lotion for treating impertigo neonatorum |
| 04/17/2013 | CN101973979B Antibacterial compound and application thereof |
| 04/17/2013 | CN101925584B Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis |
| 04/17/2013 | CN101914561B Fusion protein with antibacterial and repairing function and production method and application thereof |
| 04/17/2013 | CN101903389B Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 04/17/2013 | CN101903380B 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 04/17/2013 | CN101898966B Piperazine ring-containing Artemisia rupestris L. keto ester derivative as well as preparation method thereof |
| 04/17/2013 | CN101857540B Method for producing adipic acid, hexamethylenediamine hydrochloride and polyhexamethylene (di)guanidine chloride from nylon-66 through depolymerization |
| 04/17/2013 | CN101851631B Codon-optimized EV71 VP1 gene and nucleic acid vaccine |
| 04/17/2013 | CN101843663B Preparation method of extract package of volatile oil heavier than water |
| 04/17/2013 | CN101709078B Immune-modulating peptide |
| 04/17/2013 | CN101679437B Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 04/17/2013 | CN101647475B Incense for eliminating plague |
| 04/17/2013 | CN101646342B Disinfectant |
| 04/17/2013 | CN101613401B Nucleic acid enzyme surface protein of streptococcus suis 2-type and preparation method and application thereof |
| 04/17/2013 | CN101553483B 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/17/2013 | CN101514335B Expression and purification of influenza virus polymerase PA and crystal structure of complex of polypeptides at amino terminal of PA, carboxyl terminal of PA and amino terminal of PB1 |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/17/2013 | CN101189249B Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/17/2013 | CN101027288B HIV inhibiting 5-substituted pyrimidines |
| 04/17/2013 | CN101006092B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420646 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420115 Oral preparations and process for production thereof |
| 04/16/2013 | US8420103 Papillomavirus vaccines |
| 04/16/2013 | US8420096 Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling |
| 04/16/2013 | CA2637204C Substituted quinolones iii |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2573207C Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv) |
| 04/16/2013 | CA2568162C Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/16/2013 | CA2550581C Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation |
| 04/16/2013 | CA2534579C Live attenuated bacterial vaccine |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/16/2013 | CA2379087C Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/11/2013 | WO2013052958A2 Antimicrobial compositions and methods employing same |
| 04/11/2013 | WO2013052095A2 Vaccine |
| 04/11/2013 | WO2013052058A1 Antimicrobial compositions and methods of use thereof |
| 04/11/2013 | WO2013052012A1 Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity |
| 04/11/2013 | WO2013052010A1 Antibiotic composition and its uses |
| 04/11/2013 | WO2013052006A1 Parp-1 inhibitors |
| 04/11/2013 | WO2013051773A1 Composition for preventing and treating actinobacillus pleuropneumoniae infection |
| 04/11/2013 | WO2013051772A1 Bacteriophage having bactericidal activity with respect to actinobacillus pleuropneumoniae |
| 04/11/2013 | WO2013051597A1 Cephem derivative having catechol group |
| 04/11/2013 | WO2013051531A1 Novel anti-hcv agent |
| 04/11/2013 | WO2013051414A1 Pyrroloquinoline quinone alcohol adduct |
| 04/11/2013 | WO2013050884A1 Process for the preparation of lersivirine |
| 04/11/2013 | WO2013050625A1 Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives |
| 04/11/2013 | WO2013050426A1 Carbonic anhydrase inhibitor comprising a dithiocarbamate |
| 04/11/2013 | WO2013050422A1 Reactivation of hiv-1 gene expression to treat persistent hiv infection |
| 04/11/2013 | WO2013049941A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
| 04/11/2013 | WO2013049931A1 Recombinant b. pseudomallei adhesin protein and methods and uses thereof |
| 04/11/2013 | WO2013024157A3 Combinations of anti -hcv - entry factor antibodies, protein kinase inhibitors or alisporivir for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013024156A3 Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013006854A9 Compositions and methods for treating enterobacteriaceae |
| 04/11/2013 | WO2013006569A3 Herpes virus vaccine and methods of use |
| 04/11/2013 | WO2012170911A3 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 04/11/2013 | WO2012167237A3 Compounds having antiparasitic or anti-infectious activity |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130090362 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/11/2013 | US20130090328 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/11/2013 | US20130090312 Methods of use related to xerostomia |
| 04/11/2013 | US20130089913 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 04/11/2013 | US20130089615 Compositions of Jasmonate Compounds and Methods of Use |
| 04/11/2013 | US20130089587 Personal Care Compositions and Methods of Making Same |
| 04/11/2013 | US20130089571 Vaccine |
| 04/11/2013 | US20130089569 Recombinant mva capable of expressing structural hcv antigens |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089525 Antimicrobial compositions and methods of use thereof |
| 04/11/2013 | CA2851270A1 Dimeric bacteriophage lysins |
| 04/11/2013 | CA2851146A1 Antimicrobial compositions and methods employing same |
| 04/11/2013 | CA2850857A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |